Financials data is unavailable for this security.
View more
Year on year Phio Pharmaceuticals Corp had revenues remain flat at 0.00, though the company grew net income from a loss of 11.48m to a smaller loss of 10.83m.
Gross margin | -- |
---|---|
Net profit margin | -- |
Operating margin | -- |
Return on assets | -98.62% |
---|---|
Return on equity | -126.86% |
Return on investment | -126.86% |
More ▼
Cash flow in USDView more
In 2023, cash reserves at Phio Pharmaceuticals Corp fell by 3.34m. Cash Flow from Financing totalled 7.41m or -- of revenues. In addition the company used 10.75m for operations while cash used for investing totalled 5.00k.
Cash flow per share | -21.29 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 7.40 |
---|---|
Tangible book value per share | 7.40 |
More ▼
Balance sheet in USDView more
Current ratio | 3.47 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.00 |
---|---|
Total debt/total capital | 0.00 |
More ▼